Calling what Nasrat did a lie is not quite right, because your post shows that he made it quite clear that the BE wasn't a 'full' BE and was in fact limited. But we all have to admit that Nasrat did not openly tell us everything going on that he could have with respect to SequestOx. On the other hand he clearly qualified what was considered BE in the PR to "The study results demonstrated Elite’s product is bioequivalent to the branded drug based on pharmacokinetic measures including peak concentration (Cmax) and area under the curve (AUC) for opioid blood plasma levels. ". So he wasn't exactly not mentioning the problem.
Everyone reading it (especially all the doctors and pharmacologists) could/should have noticed this unusual qualification and caught on that something wasn't right. Anyone professionally trained who doesn't admit and recognize they had ever opportunity to catch the issue, or at least know something was up is being blinded by ego and not taking responsibility for their failure.
I agree 100% that Hakim was attempting to use weasel wording in the PR with an intent to deceive stakeholders. Unfortunately for him, he probably relied on Dianne to write it, and she or somebody managed to screw it up by adding the word "including." They could have left that word out, and they might have an argument that what they said was technically true. Likewise, they could have left out the bit at the end about the fed study and then argued it was technically true. But when they said it was fed study and it was bioequivalent, that was an incorrect statement, and adding "including PK measures Cmax and AUC..." doesn't magically somehow make it true. It is still an absolutely incorrect statement, and when we say an incorrect thing purposefully and with an intention to deceive, well my friend, that is what we call a lie... an outright lie.
The study results demonstrated Elite’s product is bioequivalent to the branded drug based on pharmacokinetic measures including peak concentration (Cmax) and area under the curve (AUC) for opioid blood plasma levels.